Angelo Delmonte

ScholarGPS® ID: 14580802409909

Affiliation

Istituto di Ricovero e Cura a Carattere Scientifico, Italy

Affiliation History

Field

Medicine

Discipline

Oncology

Top Specialties

Metrics Summary

Publication Count

190

Predicted Citations

5,403

Predicted h-index

Ranking

Publications and Citation History

Publications based on Top Specialties

Types of Publication

Publications
Books
Patents
NIH/NSF

Add Delete
Healthcare Costs and Resource Utilisation of Italian Metastatic Non-Small Cell Lung Cancer Patients (journal article) Gentili, Nicola \| Balzi, William \| Foca, Flavia \| Danesi, Valentina \| Altini, Mattia \| Delmonte, Angelo \| Bronte, Giuseppe \| Crinò, Lucio \| De Luigi, Nicoletta \| Mariotti, Marita \| ... \| Massa, Ilaria Cancers, volume 16, issue 3, pages 592- (2024). 10.3390/cancers16030592 Cite \| Source
Immunotherapy of mesothelioma: the evolving change of a long-standing therapeutic dream (journal article) Calabrò, Luana \| Bronte, Giuseppe \| Grosso, Federica \| Cerbone, Luigi \| Delmonte, Angelo \| Nicolini, Fabio \| Mazza, Massimiliano \| Di Giacomo, Anna Maria \| Covre, Alessia \| Lofiego, Maria Fortunata \| ... \| Maio, Michele Frontiers in Immunology, volume 14 (2024). 10.3389/fimmu.2023.1333661 Cited by (1) \| Cite \| Source
51P Phase IB (Ph1b), MESOVAX clinical trial of pembrolizumab (P) and dendritic cell vaccine (DCvax) in advanced pleural and peritoneal mesothelioma (M): Preliminary results (journal article) Ridolfi, L. \| Delmonte, A. \| De Rosa, F. \| Azzali, I. \| Gentili, G. \| Petrini, M. \| Pancisi, E. \| Granato, A.M. \| Bulgarelli, J. \| Doglioni, C. \| ... \| Guidoboni, M. Immuno-Oncology and Technology, volume 20 (2023). 10.1016/j.iotech.2023.100524 Cite \| Source
Circulating Tumour Cells: Detection and Application in Advanced Non-Small Cell Lung Cancer (journal article) Andrikou, Kalliopi \| Rossi, Tania \| Verlicchi, Alberto \| Priano, Ilaria \| Cravero, Paola \| Burgio, Marco Angelo \| Crinò, Lucio \| Bandini, Sara \| Ulivi, Paola \| Delmonte, Angelo International Journal of Molecular Sciences, volume 24, issue 22, pages 16085- (2023). 10.3390/ijms242216085 Cited by (2) \| Cite \| Source
EP07.04-01 Free Circulating and Extracellular Vesicles-Derived microRNA as Prognostic Biomarkers in Resected Early-Stage NSCLC: RESTING Study Results (journal article) Pasini, L. \| Petracci, E. \| Urbini, M. \| Felip, E. \| Stella, F. \| Tebaldi, M. \| Azzali, I. \| Martinez-Marti, A. \| Pancreach, E. \| Davoli, F. \| ... \| Ulivi, P. Journal of Thoracic Oncology, volume 18, issue 11, pages S543- (2023). 10.1016/j.jtho.2023.09.1014 Cite \| Source
LBA62 Durvalumab after radiotherapy (RT) in patients with unresectable stage III NSCLC ineligible for chemotherapy (CT): Primary results from the DUART study (journal article) Filippi, A.R.R. \| García-Campelo, M.R. \| Paoli, J-B. \| Kowalski, D. \| Bennati, C. \| Borghetti, P. \| Cortinovis, D.L. \| Delmonte, A. \| Genova, C. \| Van Hulst, S. \| ... \| Dziadziuszko, R. Annals of Oncology, volume 34 (2023). 10.1016/j.annonc.2023.10.058 Cited by (1) \| Cite \| Source
LBA61 Durvalumab (durva) after sequential chemoradiotherapy (CRT) in patients (pts) with unresectable stage III NSCLC: Final analysis from PACIFIC-6 (journal article) Garassino, M.C. \| Mazieres, J. \| Reck, M. \| Chouaid, C. \| Bischoff, H. \| Reinmuth, N. \| Cove-Smith, L.S. \| Mansy, T. \| Cortinovis, D.L. \| Migliorino, M.R. \| ... \| Faivre-Finn, C. Annals of Oncology, volume 34 (2023). 10.1016/j.annonc.2023.10.057 Cited by (1) \| Cite \| Source
2017P Comprehensive molecular profiling of small cell lung cancer patients treated with chemo-immunotherapy or chemotherapy alone (journal article) Urbini, M. \| Canale, M. \| Flospergher, M. \| Andrikou, K. \| Cravero, P. \| Pasini, L. \| Dubini, A. \| Panzacchi, R. \| Bennati, C. \| Rossi, G. \| ... \| Ulivi, P. Annals of Oncology, volume 34 (2023). 10.1016/j.annonc.2023.09.1248 Cite \| Source
The Clinical Significance of Circulating Tumor DNA for Minimal Residual Disease Identification in Early-Stage Non-Small Cell Lung Cancer (journal article) Verlicchi, Alberto \| Canale, Matteo \| Chiadini, Elisa \| Cravero, Paola \| Urbini, Milena \| Andrikou, Kalliopi \| Pasini, Luigi \| Flospergher, Michele \| Burgio, Marco Angelo \| Crinò, Lucio \| ... \| Delmonte, Angelo Life, volume 13, issue 9, pages 1915- (2023). 10.3390/life13091915 Cite \| Source
Integrated efficacy and safety of brigatinib in patients with ALK TKI-naive advanced ALK + NSCLC in the ALTA-1L and J-ALTA studies. (journal article) Camidge, D. Ross \| Sugawara, Shunichi \| Kondo, Masashi \| Kim, Hye Ryun \| Ahn, Myung-Ju \| Yang, James Chih-Hsin \| Han, Ji-Youn \| Hochmair, Maximilian J. \| Lee, Ki Hyeong \| Delmonte, Angelo \| ... \| Popat, Sanjay Journal of Clinical Oncology, volume 41, issue 16_suppl, pages 9078-9078 (2023). 10.1200/JCO.2023.41.16_suppl.9078 Cite \| Source
205P Modelling of NSCLC aPD1 responses in bronchoscopc biopsies on chip (bronchoBOCs) (journal article) Douka, Katerina \| Frantzi, M. \| Matthaiakaki-Panagiotaki, M. \| Mazzoni, F. \| Fancelli, S. \| Pilozzi, S. \| Ulivi, P. \| Antonuzzo, L. \| Delmonte, A. \| Roman, V. \| ... \| Tsoumakidou, M. Journal of Thoracic Oncology, volume 18, issue 4, pages S151- (2023). 10.1016/S1556-0864(23)00458-6 Cite \| Source
Combi-TED: A new Trial Testing Tedopi® with Docetaxel or Nivolumab in Metastatic Non-Small-Cell Lung Cancer Progressing After First Line (journal article) Landi, Lorenza \| Delmonte, Angelo \| Bonetti, Andrea \| Pasello, Giulia \| Metro, Giulio \| Mazzoni, Francesca \| Borra, Gloria \| Giannarelli, Diana \| Andrikou, Kalliopi \| Mangiola, Daniela \| ... \| Cappuzzo, Federico Future Oncology, volume 18, issue 40, pages 4457-4464 (2022). 10.2217/fon-2022-0913 Cited by (1) \| Cite \| Source
Durvalumab After Sequential Chemoradiotherapy in Stage III, Unresectable NSCLC: The Phase 2 PACIFIC-6 Trial (journal article) Garassino, Marina C. \| Mazieres, Julien \| Reck, Martin \| Chouaid, Christos \| Bischoff, Helge \| Reinmuth, Niels \| Cove-Smith, Laura \| Mansy, Talal \| Cortinovis, Diego \| Migliorino, Maria R. \| ... \| Faivre-Finn, Corinne Journal of Thoracic Oncology, volume 17, issue 12, pages 1415-1427 (2022). 10.1016/j.jtho.2022.07.1148 Cited by (47) \| Cite \| Source
KRAS G12 isoforms exert influence over up-front treatments: A retrospective, multicenter, Italian analysis of the impact of first-line immune checkpoint inhibitors in an NSCLC real-life population (journal article) Fancelli, Sara \| Caliman, Enrico \| Mazzoni, Francesca \| Paglialunga, Luca \| Gatta Michelet, Marta Rita \| Lavacchi, Daniele \| Berardi, Rossana \| Mentrasti, Giulia \| Metro, Giulio \| Birocchi, Ilaria \| ... \| Antonuzzo, Lorenzo Frontiers in Oncology, volume 12 (2022). 10.3389/fonc.2022.968064 Cited by (4) \| Cite \| Source
Prognosis of ALK-rearranged non-small-cell lung cancer patients carrying TP53 mutations (journal article) Canale, Matteo \| Petracci, Elisabetta \| Cravero, Paola \| Mariotti, Marita \| Minuti, Gabriele \| Metro, Giulio \| Ludovini, Vienna \| Baglivo, Sara \| Puccetti, Maurizio \| Dubini, Alessandra \| ... \| Ulivi, Paola Translational Oncology, volume 23 (2022). 10.1016/j.tranon.2022.101471 Cited by (4) \| Cite \| Source
Real-World Outcomes and Treatments Patterns Prior and after the Introduction of First-Line Immunotherapy for the Treatment of Metastatic Non-Small Cell Lung Cancer (journal article) Danesi, Valentina \| Massa, Ilaria \| Foca, Flavia \| Delmonte, Angelo \| Crinò, Lucio \| Bronte, Giuseppe \| Ragonesi, Maria \| Maltoni, Roberta \| Manunta, Silvia \| Cravero, Paola \| ... \| Altini, Mattia Cancers, volume 14, issue 18, pages 4481- (2022). 10.3390/cancers14184481 Cited by (3) \| Cite \| Source
1048P Molecular predictors of immunotherapy efficacy in lung squamous-cell carcinoma (LSCC): Results from the randomized prospective SQUINT trial (journal article) Cappuzzo, F. \| Delmonte, A. \| Landi, L. \| Andrikou, K. \| Dal Maso, A. \| Minuti, G. \| Lee, C. \| Wang, X. \| Papi, M. \| Metro, G. \| ... \| Bonanno, L. Annals of Oncology, volume 33 (2022). 10.1016/j.annonc.2022.07.1174 Cite \| Source
21P Circulating free and extracellular vesicles-derived microRNA as prognostic biomarkers in resected early-stage non-small cell lung cancer (journal article) Ulivi, P. \| Pasini, L. \| Petracci, E. \| Urbini, M. \| Felip, E. \| Stella, F. \| Davoli, F. \| Salvi, M. \| Beau-Faller, M. \| Tebaldi, M. \| ... \| Crinò, L. Annals of Oncology, volume 33 (2022). 10.1016/j.annonc.2022.07.049 Cite \| Source
EP08.01-030 Nivolumab+Ipilimumab Vs Platinum-Based CT+Nivolumab In Advanced Lung Squamous-Cell Carcinoma: The Randomized SQUINT Trial (journal article) Delmonte, A. \| Bonanno, L. \| Landi, L. \| Andrikou, K. \| Dal Maso, A. \| Minuti, G. \| Papi, M. \| Metro, G. \| Attili, I. \| Piantedosi, F. \| ... \| Cappuzzo, F. Journal of Thoracic Oncology, volume 17, issue 9, pages S351- (2022). 10.1016/j.jtho.2022.07.602 Cited by (1) \| Cite \| Source
P2.14-02 TP53 Mutations Affect Sensitivity to Lorlatinib in ROS1 Positive NSCLC: Final Results of the PFROST Trial (journal article) Landi, L. \| Tiseo, M. \| Heukamp, L.C. \| Menon, R. \| de Marinis, F. \| Minuti, G. \| Cortinovis, D.L. \| Delmonte, A. \| Galetta, D. \| Bertrand, M. \| ... \| Cappuzzo, F. Journal of Thoracic Oncology, volume 17, issue 9, pages S157- (2022). 10.1016/j.jtho.2022.07.258 Cited by (1) \| Cite \| Source